Unexpected Paths to IP Law with Kevin MacDonald
New Preorder Patent Owner Rights in Ex Parte Reexamination — Patents: Post-Grant Podcast
The Briefing: Documentary Fair Use After Warhol: The Tenth Circuit Gets It Right
Words Matter: How to Draft Arbitration Agreements That Hold Up in Court - Employment Law This Week®
SkadBytes Podcast | AI Regulation: EU and UK Update and What It Means in Practice
The Briefing: Frida Kahlo vs. The 11th Circuit - A Warning for IP Owners Everywhere
Navigating ICE’s Updated I-9 Audit Guidelines: What Employers Need to Know
At the Intersection of Biotech and AI with Janice Vatland
Podcast - De genérica a icónica: El glow up de una marca
JONES DAY PRESENTS®: Cross-Border Trade Secret Litigation in the U.S. Courts
How Did James Bond Spark a 50-Year Legal War Over Who Owns 007? — No Infringement Intended Podcast
Episode 406 -- AI Risks and Compliance: Building a Governance Framework
The Briefing: Taylor Swift, Trademark Law, and the Fight Over ‘Life of a Showgirl’
DOJ’s Bulk Sensitive Data Transfer Rule: Key Insights for Health Care Compliance Teams – Diagnosing Health Care
SBR-Author’s Podcast: Bribery Beyond Borders: The Hidden History and Future of the FCPA with Severin Wirz
'Urgent National Action to Save College Sports': Trump’s NIL Playbook — Highway to NIL Podcast
March Madness or Trademark Madness? The NCAA v. DraftKings Lawsuit
Protecting Your Products and Brand Online
Lemon Pound Cake and the First Amendment
Episode 402: Paul Allen: The Promise of AI, Governance and Public Trust
In the latest matter concerning Adeia Guides Inc’s (“Adeia”, formerly “Rovi Guides Inc”) patent enforcement campaign against Canadian cable service providers,1 the Federal Court held, for the first time, a party liable for...more
In Case C‑590/23 (Pelham II), the Grand Chamber of the Court of Justice of the European Union ("CJEU") has delivered a binding interpretation of the "pastiche" exception under Article 5(3)(k) of Directive 2001/29/EC ("InfoSoc...more
Can a company sue a competitor under the Lanham Act for falsely advertising that its product was first to market? According to the Ninth Circuit, the answer is no. In Vericool World, LLC v. Igloo Products Corp., No. 24-192...more
In two recent decisions, the UPC’s Court of Appeal (UPC CoA) has considered the scope of its “long-arm” jurisdiction. In Keex v. Adobe & Ors, the UPC CoA clarified that where the UPC has jurisdiction based on it being the...more
In China, the Revised Anti-Unfair Competition Law (AUCL 2025) came into effect on October 15, 2025. Although there are various amendments, this update focuses on Article 7, which corresponds to Article 6 of the 2019 version,...more
A recent UDRP dispute over the domain name VETERANO.com raises an interesting issue frequently seen in domain disputes involving dictionary-word domains: when does a trademark owner cross the line from legitimate enforcement...more
Kick-off of the FIFA World Cup 2026™ is almost here. The 2026 tournament marks the first time three nations will jointly host soccer’s most significant event, with the United States hosting for the second time, alongside...more
Artificial intelligence (AI), including generative and agentic AI, is no longer an emerging workplace tool. AI is already embedded in daily business operations—often faster and more extensively than leadership teams realize....more
In a closely watched patent dispute in the Eastern District of Texas, the USPTO and DOJ’s Antitrust Division took the unusual step of weighing in on how courts should evaluate a request for injunctive relief by a patent owner...more
AI is now a core part of creating modern marketing materials. Creative teams are using AI to create content, personalize experiences, streamline design workflows, and scale creative production faster than ever. As these AI...more
The Director of the United States Patent and Trademark Office issued a precedential ruling on May 14, 2026, denying institution of inter partes review (IPR) in Magnolia Medical Technologies, Inc. v. Kurin, Inc.,...more
In today’s digital economy, where brand identity is both a strategic asset and a frequent target of infringement, artificial intelligence (AI) is rapidly becoming indispensable in trademark enforcement. Serving as both sword...more
In our Case of the Week, the Federal Circuit affirmed a judgment that Mylan’s proposed generic hypertension drug would not infringe patents covering Actelion’s Veletri® medication....more
The recent debate over artificial intelligence and inventorship has often focused on a single question: can an AI system such as ChatGPT, DABUS, or another generative model be named as an inventor on a United States patent...more
Startup technology companies often hear—sometimes vaguely, sometimes urgently—that they “need a patent opinion” before launching a product, raising money, or entering the market....more
A federal jury in the U.S. District Court for the District of Massachusetts returned a verdict today (May 19, 2026) against Takeda Pharmaceutical Company in antitrust litigation concerning its branded constipation drug...more
On May 15, 2026, China’s National Medical Products Administration (“NMPA”) issued the Implementation Measures for Drug Trial Data Protection (the “Measures”), effective immediately,...more
Last week in Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc., the Federal Circuit delivered generic drug maker Mylan Pharmaceuticals Inc. with a notable victory when it affirmed the district court’s judgment that...more
On May 6, 2026, the Director of the U.S. Patent and Trademark Office issued bulk order institution decisions in two inter partes review (“IPR”) proceedings filed by Sarepta Therapeutics, Inc. against Genzyme relating to...more
With the decline of inter partes review (IPR) proceedings and the significant increase in ex parte reexamination (EPR) proceedings, the U.S. Patent and Trademark Office (USPTO) is allowing EPR patent owners to submit a new...more
Last year, in response to Recentive Analytics, Inc. v. Fox Corp. , we argued that the preemption doctrine should be reinstated as the central inquiry in any 101 subject matter eligibility determination. In Recentive, the...more
The Supreme Court heard oral argument on April 29, 2026, in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (No. 24-889), the closely watched skinny-label case for which the Court granted certiorari earlier this year....more
In some of our previous episodes, we’ve explored the interesting paths that Wolf Greenfield attorneys have taken as they eventually made their way to IP law. One thing that separates Wolf Greenfield from other firms is the...more
One of the things I like about government contracts work is its breadth. A single contract may implicate intellectual property, cybersecurity, export controls, labor and employment issues, domestic sourcing requirements,...more
Intellectual property shapes how businesses develop new products, protect their brands, and compete in crowded markets. Every April 26, World Intellectual Property Day celebrates the power of human creativity and this year’s...more